Previous 10 | Next 10 |
2024-05-28 13:17:59 ET Summary IQVIA provides a broad range of services to biopharma customers, including outsourced R&D services in support of clinical trials. Recent spending caution and the end of COVID-related revenue have led to modest headwinds. AI-enabled drug disco...
2024-05-27 15:57:02 ET Summary There have been numerous positive updates to IQVIA Holdings' fundamental economics since January 2023. It produced strong Q1 2024 earnings, with growth observed in all segments. Increasing returns from margin growth and capital productivity are d...
2024-05-26 09:55:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...
Overall spending in the U.S. market for medicines grew 2.5% in 2023, reaching $435Bn at net price level, reflecting a sharp decline in COVID-19 vaccines and therapeutics Spending growth was 9.9% when COVID-19 vaccines and therapeutics are excluded, driven by innovation in areas such as oncolo...
2024-05-12 00:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at 12:20 p.m. ET (9:20 a.m. local PT). A live audio w...
2024-05-08 11:10:00 ET Summary The acquisition of Propel by IQVIA was blocked by the FTC, leading both companies to walk away from the deal. Propel declared multiple dividends prior to the deal being called off, totaling over 15% on the cost basis. The fund values Propel at a ...
2024-05-07 23:59:00 ET Summary Cedar Creek Partners is a private investment partnership that focuses primarily on micro and small cap equities. Cedar Creek Partners is managed by Eriksen Capital Management LLC, a registered investment adviser. Cedar Creek increased by 2.4% in the ...
2024-05-03 05:18:14 ET Summary Veeva Systems is an under-the-radar stock with impressive revenue growth and profitability in the life sciences software industry. The company's business model relies on subscription revenues, providing opportunities for cross-selling and high retent...
2024-05-02 10:58:09 ET IQVIA Holdings Inc. (IQV) Q1 2024 Earnings Conference Call May 02, 2024 09:00 AM ET Company Participants Kerri Joseph - Senior Vice President, Investor Relations and Treasury Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman ...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $3,814 million GAAP Net Income of $363 million, Adjusted EBITDA of $887 million GAAP Diluted Earnings per Share of $1.97, Adjusted Diluted Earnings per Share of $2.64 R&D Solutions quarterly bookings of $2.7 billion, representing a book-to-bill ratio of 1.27...
IQVIA ™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024 survey, which measures both market impact and delivery effectiven...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2024 financial results before the market opens on Monday, July 22, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release ...